Kidney Health Initiative Involves Consumers
This public (FDA)/private (ASN) partnership obtains patient input throughout the lifecycle of approving new medical devices, including how patients can influence design, help to plan and implement clinical trials, and impact regulatory decisions.
Read the full article » | Posted 05-10-2017
- NKF Calls on New Administration to Prioritize Kidney Disease in the First 100 Days Posted 01-12-2021
- CMS Approves Add-On Payment For Innovative Home Dialysis Equipment Posted 12-10-2020
- Medicare Payment Changes to Support Innovation and Home Dialysis Posted 11-12-2020
- 7th Annual Kidney Patient Summit Went Virtual Posted 10-12-2020